Wet-wrap treatment with diluted corticosteroids is more effective than wet-wrap treatment with emollients only
ID
Bron
Verkorte titel
Aandoening
atopic dermatitis
atopic eczema
wet-wrap therapy
atopisch eczeem
constitutioneel eczeem
emollients
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The main endpoint concerns the comparison of the decrease of the objective SCORAD between the two groups for the various time points (=comparison of efficacy of the two therapies).
Achtergrond van het onderzoek
Rationale: Throughout the world, wet wrap therapy is advocated by dermatologists for treatment of children with severe atopic dermatitis. However, there is no consensus regarding the best method for wet wrap therapy with respect to the ointment or cream to be used under the wet dressings.
Objective: The main objective of this study is to compare the efficacy of wet wrap therapy with diluted corticosteroids versus wet wrap therapy with emollients. The secondary objectives are to develop an effective and objective value for monitoring the severity of atopic dermatitis, to monitor quality of life during therapy and to evaluate the safety of both therapies.
Study design: A prospective, double-blind, randomised, multi center intervention study.
Study population: Children 6 months-6 years old with severe atopic dermatitis (objective SCORAD ¡Ý 40).
Intervention: Patients will be randomised over 2 groups: the first group receives therapy with diluted corticosteroid cream under wet wraps and the second group receives emollients under wet-wraps.
Main study endpoint: The main endpoint of the study is the comparison of the decrease of the objective SCORAD between the two groups for the various time points.
Doel van het onderzoek
Wet-wrap treatment with diluted corticosteroids is more effective than wet-wrap treatment with emollients only
Onderzoeksopzet
Day 1, 4, 7, 14, 28.
Onderzoeksproduct en/of interventie
Wet-wrap therapy with diluted corticosteroid cream (mometason-furoaat with vaseline 20% cetomacrogolcream dilution 1:19 face and 1:3 body) vs. wet-wrap therapy with emollients (vaseline 20% cetomacrogolcream).
Publiek
Erasmus MC en KinderHaven, Rotterdam
Arnold P. Oranje
Rotterdam
The Netherlands
+31(010) 703 6656/6653/2697 of (010) 404 3700
a.p.oranje@erasmusmc.nl
Wetenschappelijk
Erasmus MC en KinderHaven, Rotterdam
Arnold P. Oranje
Rotterdam
The Netherlands
+31(010) 703 6656/6653/2697 of (010) 404 3700
a.p.oranje@erasmusmc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Age 6 months - 6 years at inclusion
2. Diagnosis of atopic dermatitis with an objective SCORAD > 40
3. Parent/legal guardian willing to comply with the protocol
4. Written, dated consent for subject to participate
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Known pre-existing, serious underlying disease
2. (Secondary) infected eczema:
- In case of overt impetiginisation, wet wrapping should be delayed until 48-72 hours after commencing antibiotics and confirmation of appropriate treatment by skin swab results
- Eczema herpeticum is an absolute contraindication for the use of wet dressings
3. Signs and symptoms of systemic infection (such as fever, defined as a temperature equivalent to a rectal temperature greater than 38.3ºC)
4. Problems in the hypothalamus-pituitary-adrenal (HPA) axis
5. Systemic corticosteroid therapy
6. Severe growth retardation
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL1201 |
NTR-old | NTR1246 |
Ander register | MEC : 2008-077 |
ISRCTN | ISRCTN wordt niet meer aangevraagd |